Role of proteoglycans in endochondral ossification: inhibition of calcification.
Proteoglycans from bovine nasal septa and from the Swarm rat chondrosarcoma were isolated as aggregates (PGC) and as monomers (PGS). Portions of the PGC preparations were degraded with cathepsin D or chondroitinase AC. Chondroitin sulfates were isolated by differential precipitation from alkaline digests of the PGS from bovine nasal septa. The effects of these preparations at concentrations up to 2 mg/ml on the precipitation of tricalcium phosphate in vitro at pH 7.8 in 16 hours at 25 degrees C were ascertained. To this end, the amounts of calcium and phosphate in the precipitates and in the supernates were determined. The PGC preparations were found to be very effective inhibitors; in the presence of 2 mg/ml, precipitate did not form. The PGS preparations were less effective than the PGC preparations; in the presence of 2 mg/ml, about 20% as much calcium phosphate precipitated as in their absence. The chondroitinase AC-degraded preparations at concentrations equivalent to 2 mg/ml of the PGC preparations were approximately as effective as the PGS preparations. On the other hand, the cathepsin D-degraded PGC preparations and the chondroitin sulfate chains were relatively poor inhibitors. Although the viscosity of the solutions may have influenced the rate at which the precipitates settled to the bottom of the tubes, the amounts of the tricalcium phosphate formed were related to the composition and concentration of the proteoglycan preparations.
D000818:Animals; D002113:Calcification, Physiologic / Q000187:drug effects*; D002130:Calcium Phosphates / Q000378:metabolism; D002356:Cartilage / Q000378:metabolism* / Q000502:physiology; D002417:Cattle; D011232:Chemical Precipitation; D002813:Chondrosarcoma / Q000378:metabolism / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D011509:Proteoglycans / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains
D002130:Calcium Phosphates; D011509:Proteoglycans